Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deoxyribonucleic acid (DNA) is a double-helical nucleic acid macromolecule composed of two complementary antiparallel strands of nucleotide polymers, encoding the genetic blueprint for all living organisms and directing cell function through the storage and transmission of hereditary information[1][2][3][4]. Cellular macromolecules include not just DNA, but proteins, polysaccharides, and lipids—large, complex assemblies of covalently bonded atoms essential for structural support, metabolism, signaling, and genetic fidelity[5][6]. Targeting "DNA and other cellular macromolecules" is a fundamentally non-specific therapeutic strategy, as these molecules include the basic constituents of all cells and are not specific to disease states or unique to particular cell types. Many chemotherapeutic and antimicrobial agents act by damaging DNA or interfering with key macromolecular structures or processes, resulting in anti-proliferative or cytotoxic effects but also significant risks of harming normal tissue[4][5][7]. **Note:** - The term “DNA and other cellular macromolecules” is too broad and insufficiently specific to be considered a canonical drug target. DNA is a molecular class (nucleic acid), not an individual gene, protein, or receptor. “Other cellular macromolecules” encompasses essentially all major biological classes of molecules and is not an accepted pharmacological target term. Therefore, “is_incorrect” is marked true in this case.
Intercalation into DNA, Alkylation or cross-linking of DNA, Inhibition of DNA synthesis or repair, Inhibition of topoisomerase enzymes, Chain termination during DNA/RNA extension, Disruption of supercoiling, Induction of DNA damage
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic acid and other cellular macromolecules (DNA (for deoxyribonucleic acid); none for "other cellular macromolecules" as a grouped term).